Key Insights

Highlights

Treatment Research

2 treatments under study, led by Pcp

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Pcp1
  • Angiotensin Ii Receptor Blockers Arbs Losartan And Calcium Channel Blockers Ccb Amlodipine1

Active Sponsors

  • Texas Health Resources1
  • Rong Zhang1
  • Michigan State University1
  • National Institute on Aging (NIA)1

Top Investigators

Related Conditions

  • Subjective Cognitive Decline1
  • Cognitively Normal Older Adults1
  • Hypertension1

Activity Timeline